Literature DB >> 16284456

Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Bence Rethi1, Caroline Fluur, Ann Atlas, Malgorzata Krzyzowska, Frida Mowafi, Sven Grützmeier, Angelo De Milito, Rino Bellocco, Kerstin I Falk, Eva Rajnavölgyi, Francesca Chiodi.   

Abstract

OBJECTIVE: Elevated levels of interleukin (IL)-7 are present in the blood of HIV-positive patients and it is known that IL-7 receptor (IL-7R)alpha expression decreases on T cells during HIV infection. The subset(s) of T cells with low IL-7Ralpha and the consequence of low IL-7Ralpha expression for T-cell survival are poorly characterized.
DESIGN: The frequency of IL-7Ralpha-negative T cells in HIV-positive patients was studied in relation to CD4 T-cell counts, IL-7 concentration and survival in culture. We analysed IL-7Ralpha expression in different T-cell populations and in relation to Bcl-2 expression.
METHODS: Specimens from 38 HIV-1 patients and 17 controls were examined. IL-7Ralpha and Bcl-2 expression in different T-cell populations was studied by flow cytometry. The influence of IL-7Ralpha expression on T-cell survival was studied by culturing T cells in the presence of IL-7.
RESULTS: Down-regulation of IL-7Ralpha on T cells correlated with depletion of CD4 T cells (P < 0.001) and also with increased concentration of serum IL-7 (P < 0.05). The decreased IL-7Ralpha expression was associated with low Bcl-2 expression and with the reduced survival capacity of T cells in the presence of IL-7 in vitro. Particularly, T cells with memory phenotype showed a decreased IL-7Ralpha expression in association with CD28 down-regulation.
CONCLUSIONS: The positive effects of IL-7 on survival and homeostatic proliferation of T cells might be severely impaired in HIV-infected individuals due to IL-7Ralpha down-regulation. Differentiation towards a CD28-negative memory phenotype in response to chronic activation may lead to an overall decrease of IL-7 mediated survival within the peripheral T-cell pool.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284456     DOI: 10.1097/01.aids.0000189848.75699.0f

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  53 in total

1.  Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Authors:  Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

2.  Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infection.

Authors:  Alison M O'Connor; Angela M Crawley; Jonathan B Angel
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

3.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 4.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

5.  Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Authors:  Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

6.  Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.

Authors:  Carey L Shive; Joseph C Mudd; Nicholas T Funderburg; Scott F Sieg; Benjamin Kyi; Doug A Bazdar; Davide Mangioni; Andrea Gori; Jeffrey M Jacobson; Ari D Brooks; Jeffrey Hardacre; John Ammori; Jacob D Estes; Timothy W Schacker; Benigno Rodriguez; Michael M Lederman
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

7.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

8.  Immunologic and virologic events in early HIV infection predict subsequent rate of progression.

Authors:  Anuradha Ganesan; Pratip K Chattopadhyay; Tess M Brodie; Jing Qin; Wenjuan Gu; John R Mascola; Nelson L Michael; Dean A Follmann; Mario Roederer
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals.

Authors:  Lia Vassena; Michael Proschan; Anthony S Fauci; Paolo Lusso
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

10.  Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma.

Authors:  Sylvie Faucher; Angela M Crawley; Wendy Decker; Alice Sherring; Dragica Bogdanovic; Tao Ding; Michele Bergeron; Jonathan B Angel; Paul Sandstrom
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.